e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters
Price Laura C., Devaraj Anand, Wort S. John
Source:
Eur Respir J 2016; 47:1318-1320
Journal Issue:
May
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Price Laura C., Devaraj Anand, Wort S. John. Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters. Eur Respir J 2016; 47:1318-1320
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
The contributing factors to mean pulmonary artery pressure in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 47:1445-1451
Year: 2016
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012
Right ventricular REMODELING in idiopathic pulmonary fibrosis with or without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005
Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis
Source: Eur Respir J 2016; 47: 673-676
Year: 2016
Accelerated ageing in idiopathic pulmonary fibrosis and pulmonary hypertension
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Pulmonary hypertension in idiopathic pulmonary fibrosis: correlation to pulmonary function and exercise parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013
Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept